KRAS and gastric cancer: Deregulation of canonical oncogenic pathways such as E2F, K-RAS, p53, and Wnt/b-catenin signaling are known to occur with varying frequencies in GC[15-17], suggesting that GC is a heterogeneous disease with multiple molecular defects.